Literature DB >> 15573056

Private sector hospital response to the 2003 dengue outbreak in the Indian capital metropolis of Delhi.

Subhash C Arya1, S Rajagopal, Nirmala Agarwal, Mridul Kaushik, P Maheshwari, Shekhar Agarwal, Kamini Singh, Seema George.   

Abstract

During 2003, the Indian capital metropolis of Delhi was afflicted with an outbreak of dengue. A private-sector tertiary care hospital responded instantly to the sudden influx of 162 patients during an 8-week interval. That was an unusual challenge because, until 1997, the hospital had exclusively managed patients with ophthalmic disorders. Dengue patients received fiscal concessions and several free services. A multidisciplinary cell was commissioned for case management. Apart from a diagnosis of patients with dengue and their clinical management, suspected or confirmed dengue episodes were instantly reported to health authorities. Anti-mosquito measures in the hospital premises including residential areas for the nursing personnel prevented any local virus transmission. The integrated therapeutic and public health response was associated with a 1.23% case fatality rate. The protocol developed during the dengue outbreak would address every locally reportable disease in the future.

Entities:  

Mesh:

Year:  2004        PMID: 15573056     DOI: 10.1016/j.ajic.2004.02.006

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  2 in total

1.  Simultaneous Detection of Dengue NS1 Antigen, IgM plus IgG and Platelet Enumeration during an Outbreak.

Authors:  Subhash C Arya; Nirmala Agarwal; Satibh C Parikh; Shekhar Agarwal
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

Review 2.  Factors that enable effective One Health collaborations - A scoping review of the literature.

Authors:  Kaylee Myhre Errecaborde; Katelyn Wuebbolt Macy; Amy Pekol; Sol Perez; Mary Katherine O'Brien; Ian Allen; Francesca Contadini; Julia Yeri Lee; Elizabeth Mumford; Jeff B Bender; Katharine Pelican
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.